RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R-CHOP, R-MCP, R-FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO

Authors :: Judith Dierlamm
M. Hänel
Gerald Wulf
Michael Unterhalt
Norbert Frickhofen
Eva Hoster
Hanns-Detlev Harich
Eva Lengfelder
Andreas Rosenwald
Michael Herold
Gabriele Prange-Krex
U. Graeven
A. Ahmed
Roswitha Forstpointner
Wolfgang Hiddemann
Christian A. Lerchenmuller
L. Fischer von Weikersthal
Rudolf Schlag
Martin Dreyling
A. Florschütz
W. Klapper
Source :: Hematological Oncology. 35:32-32
Publication Year :: 2017
Publisher :: Wiley, 2017.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Follicular lymphoma
Hematology
General Medicine
medicine.disease
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Immunology
medicine
Rituximab
business
030215 immunology
medicine.drug

Tools